Associate Professor of Radiology Birjand University Medical Science. Fellowship of of Interventional Radiology



Areview ofApplying Transarterial Chemoembolization (TACE) Method for Management of Hepatocellular Carcinoma Abstract Liver cancer is  one  of  the  most ordinary reasons of death among cancers. Hepatocellular carcinoma (HCC) is the  most common type of liver cancers. In spite of the fact that, various remedial methods have been approved, particularly the survival effects of transcatheter arterial chemoembolization (TACE) method has been accomplished widely in HCC treatment. By applying TACE method correctly good survival outcomes could be achieved without any harmfully affecting on hepatic functions. Transarterial chemoembolization (TACE) mixes the effect of avascular necrosis (AVN) with the effect of regional chemotherapy those are under the influence of arterial embolization. By knowing this fact that the metastases of liver cancer and also perfusion indices in hepatocellular carcinoma (HCC) are via hepatic arteries, doctors choose TACE method for treatment of liver cancer. On the other hand, in this method the radiologists are able to easily convey antitumor remedies via the arteries. Anyway, medium level HCC is a sensitive stage of heterogeneous disease that many patients suffer from, so specialists must consider it as a hazardous syndrome. TACE procedure could be applied just in cases that the liver function of patients is appropriate yet, the patient liver portal vein don’t have any problems and the patients don’t have ascites disorder. This review is aimed to figure out  the  evidence  advantages  of  TACE   specially by a comprehensive view on medium level HCC because of that this treatment method is suggested  as first line remedy. At last, the future landscape of initial factors of research in managing HCC disorder have been summarized. Keywords: Hepatocellular carcinoma, Transarterial chemoembolization, Arterial embolization, Treatment

Volume 35, Issue 2
May 2019
Pages 65-65
  • Receive Date: 05 January 2020
  • Accept Date: 05 January 2020
  • First Publish Date: 05 January 2020